vaayaa Inclusive Education
Healthcare 1 min read

FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

Apr 24, 2026

The U.S. Food and Drug Administration today approved Kresladi (marnetegragene autotemcel), the first gene therapy for the treatment of severe Leukocyte Adhesion Deficiency Type I (LAD-I).

Read full article on FDA Press Releases →

Source: FDA Press Releases — US Government, Public Domain

More in Healthcare

Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread The Conversation Health · 2 min Autistic children drown at alarming rates - swim lessons and water safety strategies can save their lives The Conversation Health · 2 min FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing FDA Press Releases · 1 min FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol FDA Press Releases · 1 min